RVTYNEUTRAL

RVTY EV/EBITDA Analysis

19.2x

Higher than 53% of Healthcare sector peers

Updated 1144h ago·SEC filings & market data

Key Takeaway

EV/EBITDA compares a company’s total value (including debt) to its earnings before interest, taxes, depreciation, and amortization.

Sector Performance

53th percentile

RVTY

19.2x

Sector Median

16.8x

Sector Avg

29.3x

Prior Period

17.0x(Jul 2026)

↓ Declining

📊

Deep Analysis

EV/EBITDA compares a company’s total value (including debt) to its earnings before interest, taxes, depreciation, and amortization.

A current multiple of 17.0x means investors are paying $17 for each dollar of those earnings. This is above the healthcare sector’s median of 14.8x, placing Revvity in the 56th percentile among peers — slightly more expensive than the typical peer. Over the last eight quarters the metric has been stable: it declined 3.6% year-over-year but edged up 1.3% quarter-over-quarter. The combination of a moderately elevated level with a flat trend suggests no acute overvaluation, but little room for multiple expansion. That balanced profile aligns with the overall NEUTRAL verdict, as the metric neither signals a cheap opportunity nor a clear risk of compression.

Frequently Asked Questions

What does the EV/EBITDA tell investors about RVTY?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does RVTY's EV/EBITDA compare to its sector?

RVTY's EV/EBITDA of 19.2x compares to a Healthcare sector median of 16.8x, placing it in the 53th percentile.

Who are RVTY's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: CAH (14.4x), DGX (14.3x), ABT (19.5x), AMGN (14.0x), ALGN (13.5x).

📚

Learn More About EV/EBITDA

EV/EBITDA Explained: The Valuation Metric Pro Investors Actually Use

Learn what EV/EBITDA is, why it beats P/E for capital-heavy companies, typical sector ranges, and key limitations every serious investor should know.

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.